141 related articles for article (PubMed ID: 7832476)
1. Neurotrophism, mitogenesis, and nerve regeneration as models for neuropeptide mediation. Introduction to Part VI.
Brenneman DE
Ann N Y Acad Sci; 1994 Oct; 739():226-7. PubMed ID: 7832476
[No Abstract] [Full Text] [Related]
2. Region-specific regulation of neurogenesis by VIP and PACAP: direct and indirect modes of action.
DiCicco-Bloom E
Ann N Y Acad Sci; 1996 Dec; 805():244-56; discussion 256-8. PubMed ID: 8993407
[No Abstract] [Full Text] [Related]
3. [The neuropeptide PACAP: its presence, its mode of action and its receptors].
Christophe J
Bull Mem Acad R Med Belg; 1993; 148(3-4):188-93. PubMed ID: 7906174
[TBL] [Abstract][Full Text] [Related]
4. Multiple receptors for PACAP and VIP.
Harmar T; Lutz E
Trends Pharmacol Sci; 1994 Apr; 15(4):97-9. PubMed ID: 7912462
[No Abstract] [Full Text] [Related]
5. Interplay of VIP and nitric oxide in the regulation of neuromuscular function in the gut.
Murthy KS; Grider JR; Jin JG; Makhlouf GM
Ann N Y Acad Sci; 1996 Dec; 805():355-62; discussion 362-3. PubMed ID: 8993416
[No Abstract] [Full Text] [Related]
6. 3rd International Symposium on VIP, PACAP, and Related Peptides. Freiburg, Germany, September 17-20, 1997. Abstracts.
Regul Pept; 1997 Aug; 71(2):103-51. PubMed ID: 9446114
[No Abstract] [Full Text] [Related]
7. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
Cavallaro S; Copani A; D'Agata V; Musco S; Petralia S; Ventra C; Stivala F; Travali S; Canonico PL
Mol Pharmacol; 1996 Jul; 50(1):60-6. PubMed ID: 8700120
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide action in sympathetic ganglia. Evidence for distinct functions in intact and axotomized ganglia.
Zigmond RE
Ann N Y Acad Sci; 2000; 921():103-8. PubMed ID: 11193812
[No Abstract] [Full Text] [Related]
9. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.
Nakata M; Kohno D; Shintani N; Nemoto Y; Hashimoto H; Baba A; Yada T
Neurosci Lett; 2004 Nov; 370(2-3):252-6. PubMed ID: 15488333
[TBL] [Abstract][Full Text] [Related]
10. VIP and PACAP receptor-mediated actions on cell proliferation and survival.
Waschek JA
Ann N Y Acad Sci; 1996 Dec; 805():290-300; discussion 300-1. PubMed ID: 8993411
[No Abstract] [Full Text] [Related]
11. Activation of pituitary adenylate cyclase-activating polypeptide receptors prevents apoptotic cell death in cultured cerebellar granule cells.
Canonico PL; Copani A; D'Agata V; Musco S; Petralia S; Travali S; Stivala F; Cavallaro S
Ann N Y Acad Sci; 1996 Dec; 805():470-2. PubMed ID: 8993425
[No Abstract] [Full Text] [Related]
12. Pituitary adenylate cyclase-activating polypeptides, PACAP-38 and PACAP-27, regulation of sympathetic neuron catecholamine, and neuropeptide Y expression through activation of type I PACAP/VIP receptor isoforms.
Braas KM; May V
Ann N Y Acad Sci; 1996 Dec; 805():204-16; discussion 217-8. PubMed ID: 8993404
[TBL] [Abstract][Full Text] [Related]
13. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
14. Effects of pituitary adenylate cyclase-activating polypeptide on facial nerve recovery in the Guinea pig.
Kimura H; Kawatani M; Ito E; Ishikawa K
Laryngoscope; 2003 Jun; 113(6):1000-6. PubMed ID: 12782812
[TBL] [Abstract][Full Text] [Related]
15. PACAP functions as a neurotrophic factor.
Arimura A; Somogyvari-Vigh A; Weill C; Fiore RC; Tatsuno I; Bay V; Brenneman DE
Ann N Y Acad Sci; 1994 Oct; 739():228-43. PubMed ID: 7726997
[No Abstract] [Full Text] [Related]
16. Role of PACAP in the regulation of gastrointestinal motility.
Katsoulis S; Schmidt WE
Ann N Y Acad Sci; 1996 Dec; 805():364-78. PubMed ID: 8993417
[No Abstract] [Full Text] [Related]
17. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
[TBL] [Abstract][Full Text] [Related]
18. Involvement of pituitary adenylate cyclase-activating peptide in opossum internal anal sphincter relaxation.
Chakder S; Rattan S
Am J Physiol; 1998 Oct; 275(4):G769-77. PubMed ID: 9756508
[TBL] [Abstract][Full Text] [Related]
19. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
20. Structural simplification of potent growth hormone-releasing hormone analogs: implications for other members of the VIP/GHRH/PACAP family.
Coy DH; Jiang NY; Fuselier J; Murphy WA
Ann N Y Acad Sci; 1996 Dec; 805():149-58. PubMed ID: 8993400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
